Page last updated: 2024-08-24

simendan and Coronary Artery Stenosis

simendan has been researched along with Coronary Artery Stenosis in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (85.71)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eriksson, HI; Heikkinen, LO; Jalonen, JR; Kivikko, M; Kuitunen, AH; Kuttila, KT; Laine, M; Leino, KA; Peräkylä, TK; Salmenperä, MT; Sarapohja, T; Suojaranta-Ylinen, RT; Valtonen, M	1
Baikoussis, NG; Karanikolas, M; Papadopoulos, G; Siminelakis, SN; Tzimas, P	1
Bernhard-Abt, A; Ettner, U; Heimisch, W; Lange, R; Mendler, N; Schad, H; Tassani, P	1
Pieske, B	1
Carmona Aurioles, J; Delange Segura, L; Jerez Anera, M; Rodríguez Fernández, S	1
Ewert, P; Hetzer, R; Lange, PE; Luther, YC; Mühler, EG; Nasseri, B; Redlin, M; Schulze-Neick, I; Stiller, B	1
Reuter, H; Schwinger, RH; Zobel, C	1

Trials

1 trial(s) available for simendan and Coronary Artery Stenosis

Article	Year
Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. The Annals of thoracic surgery, 2009, Volume: 87, Issue:2 Topics: Aged; Analysis of Variance; Cardiopulmonary Bypass; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Double-Blind Method; Education, Medical, Continuing; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Monitoring, Intraoperative; Postoperative Complications; Preoperative Care; Prospective Studies; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left	2009

Article

Year

Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.

The Annals of thoracic surgery, 2009, Volume: 87, Issue:2

Topics: Aged; Analysis of Variance; Cardiopulmonary Bypass; Confidence Intervals; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Double-Blind Method; Education, Medical, Continuing; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Monitoring, Intraoperative; Postoperative Complications; Preoperative Care; Prospective Studies; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left

2009

Other Studies

6 other study(ies) available for simendan and Coronary Artery Stenosis

Article	Year
Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction. Journal of cardiothoracic surgery, 2010, Mar-02, Volume: 5 Topics: Adrenergic alpha-Agonists; Cardiotonic Agents; Combined Modality Therapy; Coronary Artery Bypass, Off-Pump; Coronary Stenosis; Humans; Hydrazones; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Pyridazines; Renal Dialysis; Simendan	2010
Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5 Topics: Anesthesia; Animals; Cardiac Output; Coronary Stenosis; Coronary Vessels; Female; Heart Rate; Hemodynamics; Hydrazones; Injections, Intravenous; Male; Myocardial Contraction; Myocardial Ischemia; Pharmaceutical Vehicles; Pyridazines; Regional Blood Flow; Simendan; Swine; Vasodilator Agents; Venous Pressure	2002
Levosimendan in regional myocardial ischemia. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arrhythmias, Cardiac; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Coronary Vessels; Cyclic Nucleotide Phosphodiesterases, Type 3; Heart Rate; Hemodynamics; Humans; Hydrazones; Myocardial Contraction; Myocardial Ischemia; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Pyridazines; Regional Blood Flow; Simendan; Swine; Vasodilator Agents; Venous Pressure	2002
[Levosimendan as inotropic support during coronary surgery with extracorporeal circulation in a patient with severely depressed ventricular function]. Revista espanola de anestesiologia y reanimacion, 2003, Volume: 50, Issue:8 Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Coronary Stenosis; Extracorporeal Circulation; Heart Ventricles; Humans; Hydrazones; Male; Pyridazines; Reoperation; Simendan; Stents; Ventricular Dysfunction	2003
[Levosimendan-long-term inodilation in an infant with myocardial infarction]. Zeitschrift fur Kardiologie, 2004, Volume: 93, Issue:3 Topics: Cardiac Output, Low; Cardiotonic Agents; Coronary Stenosis; Coronary Vessel Anomalies; Echocardiography, Doppler; Electrocardiography, Ambulatory; Humans; Hydrazones; Hypertension, Pulmonary; Infant; Infant, Newborn; Long-Term Care; Male; Myocardial Infarction; Postoperative Complications; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasodilator Agents	2004
[Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan]. Medizinische Klinik (Munich, Germany : 1983), 2004, Dec-15, Volume: 99, Issue:12 Topics: Adult; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Catheterization, Swan-Ganz; Coronary Stenosis; Drug Therapy, Combination; Hemodynamics; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Male; Myocardial Infarction; Pyridazines; Receptors, Calcium-Sensing; Shock, Cardiogenic; Simendan; Stents; Vasodilator Agents	2004